JM Schwartz Publications in Medline.

Search phrase (Schwartz JM plus Obsessive-Compulsive) or (Schwartz JM plus Obsessive) or (Schwartz JM plus PET) or (Schwartz JM plus OCD)





1: Baxter LR Jr, Saxena S, Brody AL, Ackermann RF, Colgan M, Schwartz JM, Allen-Martinez Z, Fuster JM, Phelps ME.

Brain Mediation of Obsessive-Compulsive Disorder Symptoms: Evidence From Functional Brain Imaging Studies in the Human and Nonhuman Primate.

Semin Clin Neuropsychiatry. 1996 Jan;1(1):32-47.

PMID: 10229782 [PubMed - as supplied by publisher]



2: Brody AL, Saxena S, Schwartz JM, Stoessel PW, Maidment K, Phelps ME, Baxter

LR Jr.

FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder.

Psychiatry Res. 1998 Nov 9;84(1):1-6.

PMID: 9870412 [PubMed - indexed for MEDLINE]



3: Schwartz JM.

Neuroanatomical aspects of cognitive-behavioural therapy response in obsessive-compulsive disorder. An evolving perspective on brain and behaviour.

Br J Psychiatry Suppl. 1998;(35):38-44. Review.

PMID: 9829025 [PubMed - indexed for MEDLINE]



4: Saxena S, Brody AL, Schwartz JM, Baxter LR.

Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder.

Br J Psychiatry Suppl. 1998;(35):26-37. Review.

PMID: 9829024 [PubMed - indexed for MEDLINE]



5: Schwartz JM, Stoessel PW, Baxter LR Jr, Martin KM, Phelps ME.

Systematic changes in cerebral glucose metabolic rate after successful behaviour modification treatment of obsessive-compulsive disorder.

Arch Gen Psychiatry. 1996 Feb;53(2):109-13.

PMID: 8629886 [PubMed - indexed for MEDLINE]



6: Baxter LR Jr, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, Alazraki A, Selin CE, Ferng HK, Munford P, et al.

Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder.

Arch Gen Psychiatry. 1992 Sep;49(9):681-9.

PMID: 1514872 [PubMed - indexed for MEDLINE]



7: Baxter LR Jr, Schwartz JM, Guze BH, Bergman K, Szuba MP.

PET imaging in obsessive compulsive disorder with and without depression.

J Clin Psychiatry. 1990 Apr;51 Suppl:61-9; discussion 70. Review.

PMID: 2182617 [PubMed - indexed for MEDLINE]



8: Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE,Gerner RH, Sumida RM.

Reduction of prefrontal cortex glucose metabolism common to three types of depression.

Arch Gen Psychiatry. 1989 Mar;46(3):243-50.

PMID: 2784046 [PubMed - indexed for MEDLINE]



9: Baxter LR Jr, Schwartz JM, Mazziotta JC, Phelps ME, Pahl JJ, Guze BH,Fairbanks L.

Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder.

Am J Psychiatry. 1988 Dec;145(12):1560-3.

PMID: 3264118 [PubMed - indexed for MEDLINE]



10: Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE.

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls.

Arch Gen Psychiatry. 1987 Mar;44(3):211-8. Erratum in: Arch Gen Psychiatry 1987

Sep;44(9):800.

PMID: 3493749 [PubMed - indexed for MEDLINE]



11: Baxter LR Jr, Thompson JM, Schwartz JM, Guze BH, Phelps ME, Mazziotta JC, Selin CE, Moss L.

Trazodone treatment response in obsessive-compulsive disorder--correlated with shifts in glucose metabolism in the caudate nuclei.

Psychopathology. 1987;20 Suppl 1:114-22.

PMID: 3501130 [PubMed - indexed for MEDLINE]



12: Szuba MP, Baxter LR Jr, Fairbanks LA, Guze BH, Schwartz JM.

Effects of partial sleep deprivation on the diurnal variation of mood and motor activity in major depression.

Biol Psychiatry. 1991 Oct 15;30(8):817-29.

PMID: 1751624 [PubMed - indexed for MEDLINE]